STOCK TITAN
  1. Home
  2. Sec-filings
  3. EVH
  4. [Form 4] Evolent Health, Inc. Insider Trading Activity

[Form 4] Evolent Health, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GUERTIN SHAWN M reported acquisition or exercise transactions in this Form 4 filing.

Evolent Health, Inc. director Shawn M. Guertin received an equity award of 41,096 shares of Class A Common Stock in the form of restricted stock units granted at no cash cost to him. These units were issued under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.

The restricted stock units vest on the earlier of June 4, 2027, and the date of the company’s 2027 annual meeting, subject to his continued service through the vesting date. Following this award, Guertin directly holds 63,075 shares of Evolent Health Class A Common Stock.

Positive

  • None.

Negative

  • None.
Insider GUERTIN SHAWN M
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 41,096 $0.00 --
Holdings After Transaction: Class A Common Stock — 63,075 shares (Direct, null)
Footnotes (1)
  1. Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Restricted stock units granted 41,096 shares Class A Common Stock award to director Shawn M. Guertin on June 4, 2026
Price per share for grant $0.0000 per share Equity compensation award, no cash consideration
Shares held after transaction 63,075 shares Total direct holdings following the award
Vesting date trigger June 4, 2027 Vests on earlier of this date or 2027 annual meeting, subject to continued service
restricted stock units financial
"Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
vest financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Class A Common Stock financial
"Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GUERTIN SHAWN M
(Last)(First)(Middle)
C/O EVOLENT HEALTH, INC.
1812 N. MOORE STREET, SUITE 1705
(Street)
ARLINGTON VIRGINIA 22209
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock(1)06/04/2026A41,096(2)A$063,075D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
2. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Remarks:
/s/ Jonathan Weinberg, Attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Evolent Health (EVH) director Shawn M. Guertin report on this Form 4?

Shawn M. Guertin reported receiving an award of 41,096 restricted stock units of Evolent Health Class A Common Stock. The grant was made at no cash cost and increases his direct holdings to 63,075 shares after the transaction, reflecting routine director equity compensation.

How many Evolent Health (EVH) shares were granted to director Shawn M. Guertin?

He was granted 41,096 restricted stock units representing shares of Evolent Health Class A Common Stock. These units were issued under the company’s 2015 Omnibus Incentive Compensation Plan and form part of his equity-based compensation as a member of the board of directors.

When do Shawn M. Guertin’s 41,096 Evolent Health (EVH) restricted stock units vest?

The 41,096 restricted stock units vest on the earlier of June 4, 2027, and the date of Evolent Health’s 2027 annual meeting. Vesting is conditioned on Guertin’s continued service with the company through that vesting date as disclosed in the Form 4 footnotes.

How many Evolent Health (EVH) shares does Shawn M. Guertin hold after this grant?

After the reported grant, Guertin directly holds 63,075 shares of Evolent Health Class A Common Stock. This total reflects his position following the 41,096-share restricted stock unit award disclosed in the Form 4 insider transaction report filed with regulators.

Was Shawn M. Guertin’s Evolent Health (EVH) stock award an open-market purchase?

No, the transaction was a grant of restricted stock units coded as an acquisition (A), not an open-market purchase. The price per share is reported as 0.0000, indicating an equity compensation award rather than a buy order on the public market.